Amgen starts two critical late-stage trials for weight loss drug MariTide

  • Posted on March 5, 2025
  • By CNBC
  • 3 Views
Amgen starts two critical late-stage trials for weight loss drug MariTide

MariTide is a monthly injection that investors hope could compete against existing weight loss drugs from Novo Nordisk and Eli Lilly.
continue reading...

Author
CNBC

You May Also Like